Evidence map›Paper›PMID 38632499›Full record

ArticleBMC cancer2024

Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.

Alessio Cirillo, Daniele Marinelli, Umberto Romeo, Daniela Messineo, Francesca De Felice, Marco De Vincentiis, Valentino Valentini, Silvia Mezi, Filippo Valentini, Luca Vivona and 7 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Alessio CirilloDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Daniele MarinelliDepartment of Experimental Medicine, Sapienza University, 00161, Rome, Italy. daniele.marinelli@uniroma1.it.
Umberto RomeoDepartment of Oral Sciences and Maxillofacial Surgery, Sapienza University, 00161, Rome, Italy.
Daniela MessineoDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Francesca De FeliceDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Marco De VincentiisDepartment of Sense Organs, Sapienza University, 00161, Rome, Italy.
Valentino ValentiniDepartment of Oral Sciences and Maxillofacial Surgery, Sapienza University, 00161, Rome, Italy.
Silvia MeziDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Filippo ValentiniDepartment of Oral Sciences and Maxillofacial Surgery, Sapienza University, 00161, Rome, Italy.
Luca VivonaDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Antonella ChiavassaDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Bruna CerbelliDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University, 04100, Latina, Italy.
Daniele SantiniDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University, 04100, Latina, Italy.
Paolo BossiDepartment of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25121, Brescia, Italy.
Antonella PolimeniDepartment of Oral Sciences and Maxillofacial Surgery, Sapienza University, 00161, Rome, Italy.
Paolo MarchettiIstituto Dermopatico Dell'Immacolata (IDI-IRCCS), 00167, Rome, Italy.
Andrea BotticelliDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Sapienza University of Rome · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38632499
PMCPMC11022311
OpenAlexW4394883315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.